Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 151 to 200 of 2559

TitleReference numberPublishedLast updated
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment when a stem cell transplant is unsuitable (terminated appraisal)TA1083
Idecabtagene vicleucel for treating relapsed or refractory multiple myeloma after 2 to 4 treatments (terminated appraisal)TA1084
Mirikizumab for previously treated moderately to severely active Crohn's diseaseTA1080
Zanubrutinib for treating relapsed or refractory mantle cell lymphomaTA1081
One-piece closed bags for colostomies: late-stage assessmentHTG754
Pulsed-field ablation for atrial fibrillationHTG755
Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessmentHTG753
Adagrasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (terminated appraisal)TA1076
Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and overTA1077
Dapagliflozin for treating chronic kidney diseaseTA1075
Fosdenopterin for treating molybdenum cofactor deficiency type A (terminated appraisal)TA1078
Transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitationHTG752
Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodiesTA1073
Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessmentHTG751
Atezolizumab for adjuvant treatment of resected non-small-cell lung cancerTA1071
Tislelizumab for treating advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA1072
Spesolimab for treating generalised pustular psoriasis flaresTA1070
Targeted muscle reinnervation for managing limb amputation painHTG750
Caesarean birthNG192
Linzagolix for treating symptoms of endometriosisTA1067
Efgartigimod for treating antibody-positive generalised myasthenia gravisTA1069
Laparoscopic insertion of an inactive implant for gastro-oesophageal reflux diseaseHTG749
Somapacitan for treating growth hormone deficiency in people 3 to 17 yearsTA1066
Headaches in over 12s: diagnosis and managementCG150
Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (terminated appraisal)TA1068
Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA1065
Abortion careNG140
Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA1064
Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatmentTA1063
Erdafitinib for treating unresectable or metastatic urothelial cancer with FGFR3 alterations after a PD-1 or PD-L1 inhibitorTA1062
Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancerTA1060
Digital therapy for chronic tic disorders and Tourette syndrome: early value assessmentHTG748
Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphomaTA1059
Drug-eluting stents for treating coronary artery disease: late-stage assessmentHTG747
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal)TA1061
COVID-19 rapid guideline: managing COVID-19NG191
Slide sheets for moving or repositioning a person: late-stage assessmentHTG745
FallsQS86
Falls: assessment and prevention in older people and in people 50 and over at higher riskNG249
Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and overHST33
Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labourHTG744
Tislelizumab in combination for untreated advanced non-small-cell lung cancer (terminated appraisal)TA1058
Robot-assisted surgery for soft tissue procedures: early value assessmentHTG742
Robot-assisted surgery for orthopaedic procedures: early value assessmentHTG743
Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapyTA1055
Relugolix–estradiol–norethisterone for treating symptoms of endometriosisTA1057
Cladribine for treating active relapsing forms of multiple sclerosisTA1053
Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and overTA1054
Early and locally advanced breast cancer: diagnosis and managementNG101
Burosumab for treating X-linked hypophosphataemia in children and young peopleHST8

Results per page

  1. 10
  2. 25
  3. 50
  4. All